The Vaccine Infectious Disease Organization is part of the University of Saskatchewan, so we tend not to deal with that early-stage investment, where most of our discoveries or inventions are pre-licensed to some of the large pharma and biotechnology companies. So I'd have difficulty commenting on some of the challenges faced by the young start-up companies.
On May 28th, 2008. See this statement in context.